Home > Drugs A-Z > P32 Sodium Phosphate

P32 Sodium Phosphate (AnazaoHealth Corporation)

Available Formats

Dosage Form Package Information Links
INJECTION, SUSPENSION 3 mL in 1 VIAL (51808-127-01) Label Information

Complete P32 Sodium Phosphate Information

  • DESCRIPTION

    AnazaoHealth’s compounded P32 Chromic Phosphate is supplied as a sterile, nonpyrogenic aqueous solution. It contains 30 % dextrose solution, 1 mg sodium acetate, 2 % benzyl alcohol added as a preservative. Sodium hydroxide or hydrochloric acid may be added for pH adjustment.


  • INDICATIONS AND USAGE

    P32 chromic phosphate is indicated for intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease, and may be injected interstitially for the treatment of cancer. It is also used in hemophilia patients for intraarticular injections.

    Mechanism of Action

    Radioactive phosphorous works by local irradiation by beta emission.


  • CONTRAINDICATIONS

    P32 sodium phosphate should not be used in the presence of ulcerative tumors.


  • WARNINGS

    Not for intravascular injection.


  • DOSAGE AND ADMINISTRATION

    Shake the vial well before injection.

    For intraperitoneal instillation, administer 10-20 mCi

    For intrapleural instillation, administer 6 to 12 mCi

    Doses for interstitial use should be based on estimated gram weight of tumor, about 0.1 to 0.5 mCi/gm.


  • DECAY CHART

    5ed86373-figure-01

  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

    Figure 1

    5ed86373-figure-02

  • INGREDIENTS AND APPEARANCE
    P32 SODIUM PHOSPHATE 
    p32 sodium phosphate injection, suspension
    Product Information
    Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:51808-127
    Route of Administration INTRA-ARTICULAR, INTRAPERITONEAL, INTERSTITIAL, INTRAPLEURAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PHOSPHORUS P-32 (UNII: 690284A407) (PHOSPHORUS P-32 - UNII:690284A407) PHOSPHORUS P-32 5 mCi  in 1 mL
    Inactive Ingredients
    Ingredient Name Strength
    DEXTROSE (UNII: IY9XDZ35W2) 0.3 g  in 1 mL
    BENZYL ALCOHOL (UNII: LKG8494WBH) 0.02 mL  in 1 mL
    SODIUM ACETATE (UNII: 4550K0SC9B) 1 mg  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:51808-127-01 3 mL in 1 VIAL
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    Unapproved drug other 06/19/2012
    Labeler - AnazaoHealth Corporation (011038762)
    Establishment
    Name Address ID/FEI Business Operations
    AnazaoHealth Corporation 011038762 MANUFACTURE(51808-127)